期刊文献+

盐酸多西环素调释胶囊释放度与体内血药浓度相关性考察 被引量:4

Investigation of release of doxycycline hylcate modified-release pellets and in vivo-in vitro correlation
原文传递
导出
摘要 目的:测定自制盐酸多西环素调释胶囊的体内血药浓度,通过盐酸多西环素调释胶囊的体外释放度实验,利用反卷积法研究其体内外参数的相关性。方法:按中国药典2005年版二部附录释放度测定第一法,以0.06mol.L-1盐酸溶液为释放介质,采用紫外分光光度法测定多西环素累积释放百分率。采用高效液相-紫外色谱法测定多西环素人体内血清药物浓度。结果:盐酸多西环素调释胶囊体内累积吸收百分率F与体外累积释放百分数X建立的一元线性回归方程为:F=1.314 7X-32.527,r=0.981 6。结论:盐酸多西环素调释胶囊体内外相关性显著,释放度测定方法可有效控制盐酸多西环素调释胶囊的内在质量和预测其生物利用度。 OBJECTIVE To determine the serum levels of doxycycline hyclate modified-release pellets after oral administra tion and to evaluate in vivo and in vitro correlation by deconvolution method. METHODS Using the 0. 06 mol L^-1 HCI as dissolution medium, to determine the accumulative release percentage in vitro by UV and the drug levels in serum by HPLC. RESULTS The linear regressive equation was established between the absorption percentage in vivo F and accumulate release percentage in vitro X of doxycycline hyclate modified-release pellets as F = 1. 3147X - 32. 527, r = 0. 9816. CONCLUSION The results suggest that there is a significant correlation between the absorption percentage in vivo and accumulate release percent age in vitro of doxycycline hyclate modified-release pellets.
机构地区 中山大学药学院
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第8期630-634,共5页 Chinese Journal of Hospital Pharmacy
关键词 盐酸多西环素调释胶囊 释放度 血药浓度 体内外相关性 doxycycline hyclate modified-release pellets accumulate release percentage serum drug level in vivo and in vitro correlation
  • 相关文献

参考文献6

二级参考文献13

  • 1杨明世,游本刚,杨明华,寸冬梅,陶安进,崔福德.脱卷积法进行自制尼群地平缓释制剂体内外相关性研究[J].药学学报,2004,39(9):738-741. 被引量:17
  • 2戈升荣,王兰君,曹惠明,等.国产与进口美洛昔康片的生物等效性[J].中国医院药学杂志,2003,23(9增刊):34.
  • 3[2]奚念朱主编.药剂学[M].北京:人民卫生出版社,1994.514.
  • 4Balan G, Timmins P, Greene DS, et al. In vitro-in vivo correlation models for metformin after administration of modified-release oral dosage forms to healthy human volunteers [ J]. J Pharm Sci, 2001,90(8): 1176 - 1185.
  • 5Krol GJ, Lettieri JT, Yeh SC, et al. Disposition and pharmacokinetics of 14C-nitrendipine in healthy volunteers [J]. J Cardiovasc Pharmacol, 1987,9(Suppl 4) :S122-S128.
  • 6Langenbucher F, Mysicka J. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol oros preparations [J]. Br J Clin Pharmacol,1985,19:151S - 162S.
  • 7Wagner JG. Do you need a pharmacokinetic method, and if so, which one? [J] J Pharmacokin Biopharm, 1975,3(6) :457-478.
  • 8Vaughan DP, Nennis M. Mathematical basis of pointarea deconvolution method for determining in vivo input functions [J]. J Pharm Sci, 1978,67(5) :663 -665.
  • 9赵辨.新抗病毒药──万乃洛韦(valaciclovir)[J].临床皮肤科杂志,1998,27(3):190-190. 被引量:39
  • 10丁劲松,蒋学华.HPLC测定犬血浆中萘哌地尔的浓度[J].华西药学杂志,2000,15(6):423-425. 被引量:7

共引文献36

同被引文献23

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部